Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-034800
Filing Date
2021-06-28
Accepted
2021-06-28 16:26:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A abio-defa14a_20210628.htm DEFA14A 31100
  Complete submission text file 0001564590-21-034800.txt   32281
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22873 | Film No.: 211053746
SIC: 2835 In Vitro & In Vivo Diagnostic Substances